Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$494.46 USD
-11.32 (-2.24%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $494.52 +0.06 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 3.98 |
EPS Last Quarter | -12.83 |
Last EPS Surprise | -11.57% |
ABR | 1.80 |
Earnings ESP
|
-2.62% |
---|---|
Current Year | 1.65 |
Next Year | 17.73 |
EPS (TTM) | 0.21 |
P/E (F1) | 299.15 |
% EPS Growth Estimates | VRTX | IND | S&P |
---|---|---|---|
Current Qtr (09/2024) | -2.45 | 5,941.58 | 11.23 |
Next Qtr (12/2024) | -6.43 | 161.80 | 20.57 |
Current Year (12/2024) | -89.17 | 16.20 | 15.67 |
Next Year (12/2025) | 974.55 | 10.00 | 11.34 |
Past 5 Years | 38.20 | 1.00 | 8.10 |
Next 5 Years | 12.80 | 20.80 | NA |
PE | 299.15 | -8.60 | 21.65 |
PEG Ratio | 23.40 | -0.41 | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.68B | 2.72B | 10.74B | 11.83B |
# of Estimates | 9 | 9 | 11 | 11 |
High Estimate | 2.70B | 2.79B | 10.87B | 13.74B |
Low Estimate | 2.63B | 2.69B | 10.64B | 11.33B |
Year ago Sales | 2.48B | 2.52B | 9.87B | 10.74B |
Year over Year Growth Est. | 7.71% | 8.06% | 8.86% | 10.10% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.98 | 3.93 | 1.65 | 17.73 |
# of Estimates | 9 | 9 | 7 | 12 |
Most Recent Consensus | NA | 4.02 | 0.05 | 18.09 |
High Estimate | 4.30 | 4.40 | 3.75 | 22.47 |
Low Estimate | 3.64 | 3.51 | 0.05 | 15.43 |
Year ago EPS | 4.08 | 4.20 | 15.23 | 1.65 |
Year over Year Growth Est. | -2.45% | -6.43% | -89.17% | 974.49% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 1 |
Up Last 30 Days | 1 | 2 | 0 | 3 |
Up Last 60 Days | 1 | 2 | 0 | 3 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 2 | 2 | 7 | 2 |
Down Last 60 Days | 2 | 2 | 7 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 3.98 | 3.93 | 1.65 | 17.73 |
7 Days Ago | 3.98 | 3.93 | 4.06 | 17.69 |
30 Days Ago | 4.00 | 3.97 | 17.04 | 17.71 |
60 Days Ago | 4.00 | 3.97 | 17.04 | 17.68 |
90 Days Ago | 4.11 | 4.35 | 16.92 | 18.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.88 | 3.88 | 1.65 | 16.91 |
Zacks Consensus Estimate | 3.98 | 3.93 | 1.65 | 17.73 |
Earnings ESP | -2.62% | -1.43% | 0.00% | -4.65% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -12.83 | 4.76 | 4.20 | 4.08 | NA |
Estimate | -11.50 | 4.10 | 4.10 | 3.92 | NA |
Difference | -1.33 | 0.66 | 0.10 | 0.16 | -0.10 |
Surprise | -11.57% | 16.10% | 2.44% | 4.08% | 2.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more